The GoodRx Prescription Savings Blog

The latest updates on prescription drugs and ways to save from the GoodRx medical team

Lunesta Generic Now Available!

by The GoodRx Pharmacist on April 22, 2014 at 12:05 pm

Insomnia med Lunesta, first approved in 2004, is now available as generic eszopiclone! Eszopiclone received FDA approval as of April 15, 2014 and was launched this month, meaning you will be able to find it in your pharmacy soon (if it isn’t already there).

What is Lunesta (eszopiclone)?
Eszopiclone is a GABA agonist is indicated for the treatment of insomnia.

What strengths is this medication available in, and how is it usually taken?
Lunesta and eszopiclone are available in 1 mg, 2 mg, and 3 mg tablets.

The typical adult (non-elderly) dose is 2 mg to 3 mg before bedtime. However, your dose of eszopiclone should be individualized and adjusted if you have liver problems.

Is this medication considered a controlled substance or narcotic?
Yes. Lunesta (eszopiclone) is a Schedule IV controlled substance, which can potentially lead to physical and mental dependence.

What are the most common side effects?
The most common side effects of this medication include: headache, drowsiness, unpleasant taste, respiratory or viral infection, dizziness, dry mouth, rash, anxiety, or hallucinations.

There are multiple generic manufacturers with approval to make eszopiclone, so generic eszopiclone should offer significant savings over brand name Lunesta in time.


Copyright ©2015 GoodRx, Inc.

This information is for informational purposes only and is not meant to be a substitute for professional medical advice, diagnosis or treatment. GoodRx is not offering advice, recommending or endorsing any specific prescription drug, pharmacy or other information on the site. GoodRx provides no warranty for any of the pricing data or other information. Please seek medical advice before starting, changing or terminating any medical treatment. Third party logos, trademarks, brand names and images contained on GoodRx.com are for demonstration purposes only and are owned by their respective rights holders, who are not affiliated with this Site.